Company
United StatesProgenics Pharmaceuticals, Inc., Somerset, NJ – FDA Inspections
Inspection records and compliance data for Progenics Pharmaceuticals, Inc. in Somerset, New Jersey. 2 FDA inspections on record, last inspected April 21, 2023.
Company Profile
This profile covers Progenics Pharmaceuticals, Inc. based in Somerset, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected March 20, 2020. Last inspected April 21, 2023.
Most cited issue areas
- Adequate space lacking to prevent mix-ups and contamination1 inspection
- Aseptic Processing Area1 inspection
- Computer control of master formula records1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 21, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1206225 |
| March 20, 2020 | VAI | Human Drugs · Drug Quality Assurance | 1121240 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Progenics Pharmaceuticals, Inc.
FEI Number
3013995400
Address
110 Clyde Rd Ste 2, Somerset, New Jersey 08873, United States
Country
United States
ID: af57a549-061b-40d6-b52b-e1ce51283389